ARBUTUS BIOPHARMA CORPORATION — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
ARBUTUS BIOPHARMA CORPORATION — Equity RollforwardNEW
Per-period stockholders' equity flows + ending balances by component, sourced from the issuer's 10-K dimensional XBRL on us-gaap:StatementEquityComponentsAxis. Positive flows (Net Income / OCI / SBC / Stock Issuance) above the axis; negative flows (Dividends / Buybacks / Tax Withholding) below. Net change in equity per period = sum of bars.
Common + APIC
$1.5B
↑ 0.8%
Retained Earnings
−$1.4B
↓ 2.5%
AOCI
−$48.1M
↑ 0.1%
Treasury Stock
—
NCI
—
Total Equity
—
ARBUTUS BIOPHARMA CORPORATION — PP&E by TypeNEW
Capitalized-asset breakdown sourced from us-gaap:PropertyPlantAndEquipmentByTypeAxis dimensional XBRL. Surfaces the "where capex is flowing" story — servers/networking dominate cloud-infra builds (AMZN, META), upstream equipment dominates energy capex (XOM), vehicles/fleet dominate auto-OEMs (TSLA).
By CategoryAs of 2025-12-31 · Total Gross $245.0K
$245.0K
100.0% of total
—
0.0% of total
| Member | Class | Gross | Accum. Dep. | Net | Useful Life |
|---|---|---|---|---|---|
| Computer Equipment | Machinery & Equipment | $245.0K | $213.0K | $32.0K | — |
| Laboratory Equipment | Machinery & Equipment | — | — | — | — |
| Leasehold Improvements | Leasehold Improvements | — | — | — | — |